KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Neogenomics (NEO) Leases (2016 - 2025)

Neogenomics (NEO) has disclosed Leases for 15 consecutive years, with $78.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Leases fell 1.43% year-over-year to $78.4 million, compared with a TTM value of $78.4 million through Dec 2025, down 1.43%, and an annual FY2025 reading of $78.4 million, down 1.43% over the prior year.
  • Leases was $78.4 million for Q4 2025 at Neogenomics, down from $80.1 million in the prior quarter.
  • Across five years, Leases topped out at $102.3 million in Q3 2021 and bottomed at $50.9 million in Q1 2021.
  • Average Leases over 5 years is $86.1 million, with a median of $86.9 million recorded in 2023.
  • The sharpest move saw Leases soared 123.21% in 2021, then dropped 13.28% in 2024.
  • Year by year, Leases stood at $102.2 million in 2021, then dropped by 5.96% to $96.1 million in 2022, then dropped by 4.52% to $91.8 million in 2023, then decreased by 13.28% to $79.6 million in 2024, then fell by 1.43% to $78.4 million in 2025.
  • Business Quant data shows Leases for NEO at $78.4 million in Q4 2025, $80.1 million in Q3 2025, and $82.9 million in Q2 2025.